New from CADTH: Pharmaceutical Reviews Update

The Pharmaceutical Reviews Update consolidates our CDR Update, pCODR Update, Therapeutic Review Update, and Updates for Patient Groups into a single newsletter. It will make it easier for you to stay on top of changes to our review processes, and reduce the number of emails you received from CADTH.

CADTH is inviting stakeholder comments and feedback on the following initiatives: strengthening the process for establishing reimbursement criteria in CDR recommendations; posting manufacturer comments on draft CDR reports and CADTH responses; and addressing non-submissions by manufacturers.